TrumpRX: Medicareās New Weight Loss CokeāNow in Pill Form!
In a twist messier than a TikTok diet challenge, the Trump administration is creeping towards a pharma bromance with Eli Lilly and Novo Nordisk to make weight loss drugs like Wegovy and Zepbound cheaper and Medicare-eligible. Imagine Wegovy dropping to $149/month on TrumpRX (official whitehouse-tool-for-shedding-bills) while Zepbound flexes at $299. Oh, and remember the April 2025 sabotage of Bidenās $40B idea to cover these magic needles? Yeah, now Trumpās shopping that buffet again, aiming to cover these drugs for both Medicare and possibly Medicaid users. Half of obese seniors were already halfway in before this saga even began.
Share the Story
Trump's Medicare deal lets seniors lose weight for less while confusing the internet about who really hates spending big on drugs. Meanwhile, Wegovy and Zepbound are like the overpriced avocado toast of pharmaceuticals ā now 'affordable' at hundreds a month!
Medicare covering weight loss drugs finally proves the government cares about more than just Twitter polls and obscure middle names.
Drug companies dropping prices on weight loss meds after politics does the math feels like your diet: inconsistent, overpriced, but somehow still hopeful.
Source: Axios | Published: 11/4/2025 | Author: Caitlin Owens
More Articles in Health
Sam Altmanās Hospital Stay: AI Genius Vs. Semaglutide Junk Food
90-Year-Old Powerlifters Crush Age, Bones, and Expectations
Forty-Something Brits Take on Identical Triplets: Sleep, Who Needs It?
Pickleball Achilles: From Court Pop to Star-Powered Sobfest
Jennifer Anistonās 20-Minute Gym Magic Outsmarts Aging, Knee Surgeries, And Netflix Bingeing
